Dutasteride and Tamsulosin Hydrochloride Capsules

FDA Drug Profile — Dutasteride and Tamsulosin Hydrochloride

Drug Details

Generic Name
Dutasteride and Tamsulosin Hydrochloride Capsules
Brand Names
Dutasteride and Tamsulosin Hydrochloride
Application Number
ANDA202509
Sponsor
AvKARE
NDC Codes
1
Dosage Forms
CAPSULE
Routes
ORAL
Active Ingredients
DUTASTERIDE, TAMSULOSIN HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE Dutasteride and tamsulosin hydrochloride capsules are a combination of dutasteride, a 5-alpha-reductase inhibitor, and tamsulosin, an alpha-adrenergic antagonist, indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate. ( 1.1 ) Limitations of Use: Dutasteride-containing products, including dutasteride and tamsulosin hydrochloride capsules, are not approved for the prevention of prostate cancer. ( 1.2 ) 1.1 Benign Prostatic Hyperplasia (BPH) Treatment Dutasteride and tamsulosin hydrochloride capsules are indicated for the treatment of symptomatic BPH in men with an enlarged prostate. 1.2 Limitations of Use Dutasteride-containing products, including dutasteride and tamsulosin hydrochloride capsules, are not approved for the prevention of prostate cancer.